Your browser doesn't support javascript.
loading
Serologic testing of randomly selected children after hepatitis B vaccination: a cross-sectional population-based study in Lao People's Democratic Republic.
Norizuki, Masataro; Kitamura, Tomomi; Komada, Kenichi; Sugiyama, Masaya; Mizokami, Masashi; Xeuatvongsa, Anonh; Som-Oulay, Vilasak; Vongphrachanh, Phengta; Machida, Munehito; Wada, Koji; Ishii, Koji; Kiyohara, Tomoko; Wakita, Takaji; Hachiya, Masahiko.
Afiliação
  • Norizuki M; Bureau of International Health Cooperation, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan. m-norizuki@it.ncgm.go.jp.
  • Kitamura T; Graduate School of Medicine, International University of Health and Welfare Graduate School, Minato, Tokyo, Japan. m-norizuki@it.ncgm.go.jp.
  • Komada K; Bureau of International Health Cooperation, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
  • Sugiyama M; Bureau of International Health Cooperation, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
  • Mizokami M; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan.
  • Xeuatvongsa A; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan.
  • Som-Oulay V; National Immunization Program, Ministry of Health, Lao PDR, Simeuang Road, Vientiane, Lao PDR.
  • Vongphrachanh P; National Center for Laboratory and Epidemiology, Ministry of Health, Lao PDR, Simeuang Road, Vientiane, Lao PDR.
  • Machida M; National Center for Laboratory and Epidemiology, Ministry of Health, Lao PDR, Simeuang Road, Vientiane, Lao PDR.
  • Wada K; Bureau of International Health Cooperation, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
  • Ishii K; Department of Global Health, Faculty of Medicine, Institute of Medical, Pharmaceutical and health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Kiyohara T; Bureau of International Health Cooperation, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
  • Wakita T; Graduate School of Medicine, International University of Health and Welfare Graduate School, Minato, Tokyo, Japan.
  • Hachiya M; Department of Virology II, National Institute of Infectious Diseases, Musashi-murayama, Tokyo, Japan.
BMC Infect Dis ; 19(1): 507, 2019 Jun 10.
Article em En | MEDLINE | ID: mdl-31182043
BACKGROUND: Population immunity against hepatitis B virus (HBV) in Lao People's Demographic Republic (PDR) has not been examined since the national HBV vaccination program was started in 2002. Vaccine has been observed to be frozen at times during cold-chain transport in vaccination programs in Lao PDR and other developing countries, which will inactivate the vaccine. Therefore, this study used post-vaccination serologic testing to evaluate the effects of HBV immunization in Lao PDR. METHODS: A cross-sectional serologic study was conducted among children (age range, 5-9 years) and mothers (15-45 years) who were randomly selected using probability-proportional-to-size sampling from central Lao PDR. Blood samples were collected as dried blood spots (DBS) and analyzed using chemiluminescent microparticle immunoassay to detect anti-hepatitis B surface (HBs) titers. We also evaluated the correlation between anti-HBs levels measured in DBS and serum among healthy healthcare workers in Vientiane. RESULTS: Anti-HBs titers from DBS were strongly correlated with serum levels (correlation coefficient = 0.999) in all 12 healthcare workers evaluated. A linear regression model showed that 10 mIU/mL of serum anti-HBs was equivalent to 3.45 mIU/mL (95% CI: 3.06-3.85) of DBS. Among 911 mother-child pairs tested, 171 children had documentation of vaccination. Of the 147 children who had received ≥3 doses of the hepatitis B vaccine, 1 (0.7%) was positive for anti-HBs. The remaining 24 children received the hepatitis B vaccine only twice, once or no dose. CONCLUSIONS: The results showed extremely low positivity for anti-HBs among vaccinated children in central Lao PDR. Therefore, post-vaccination serologic testing is important to evaluate population immunity against HBV infection. DBS testing is a potential low-cost tool to evaluating the effectiveness of HBV vaccination programs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas contra Hepatite B / Anticorpos Anti-Hepatite B Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: BMC Infect Dis Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas contra Hepatite B / Anticorpos Anti-Hepatite B Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: BMC Infect Dis Ano de publicação: 2019 Tipo de documento: Article